Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study

Jitao Wang, Zhanguo Zhang, Dong Shang, Jinlong Li, Chengyu Liu, Peng Yu, Mingguang Wang, Dengxiang Liu, Hongrui Miao, Shuang Li, Biao Zhang, Anliang Huang, Yewei Zhang, Shubo Chen, Xiaolong QiFrontiers in Oncology 2022 · DOI

TL;DR

Researchers have developed a simple, noninvasive three-tier grading system for portal hypertension (PH) that effectively predicts the risk of liver failure after surgery in patients with hepatocellular carcinoma. By combining this PH grade with the planned extent of liver resection, surgeons can use a new "roadmap" to identify high-risk patients and potentially avoid fatal post-operative complications.

What Problem Does This Paper Address?

For patients with hepatocellular carcinoma (HCC)—the most common type of primary liver cancer—surgical removal of the tumor (hepatectomy) is often the best chance for a cure. However, the procedure carries a significant risk: Post-Hepatectomy Liver Failure (PHLF), which remains a leading cause of death following surgery.

Portal hypertension (PH), or high blood pressure in the liver's primary vein, is a major red flag for PHLF. While the "gold standard" for measuring PH is an invasive procedure called Hepatic Venous Pressure Gradient (HVPG) measurement, it is technically difficult, expensive, and involves radiation exposure, making it impractical for routine use. Previous clinical guidelines often treated PH as a simple "yes/no" contraindication for surgery. This paper addresses the need for a nuanced, noninvasive way to grade PH severity and determine how that severity interacts with surgical scope to predict patient outcomes.

Methods

This was a multicenter retrospective study analyzing data from 659 HCC patients across four major hospitals in China who underwent hepatectomy between 2012 and 2020.

The researchers' primary innovation was a simplified, noninvasive PH grading system (Grades 0, 1, and 2) based on two indirect clinical markers:

  1. Varicose veins: Presence of obvious esophagogastric varices (detected via imaging or endoscopy).
  2. Splenomegaly + Low Platelets: An enlarged spleen combined with a platelet count below $100 \times 10^9/L$.
  3. Grade 0: Neither marker present.
  4. Grade 1: One marker present.
  5. Grade 2: Both markers present.

The team used univariate and multivariate logistic regression to identify independent risk factors for PHLF. They also employed Propensity Score Matching (PSM) to balance baseline variables between groups, ensuring that the predictive power of the PH grade wasn't just a byproduct of other underlying health differences.

Datasets

The study utilized a multicenter cohort of 659 patients with histopathologically confirmed HCC. The data was drawn from:

  • Xingtai People’s Hospital
  • Fifth Medical Center of PLA General Hospital
  • Affiliated Hospital of Huazhong University of Science and Technology
  • First Affiliated Hospital of Dalian Medical University

No new public benchmarks or external datasets were introduced; the study relied on clinical records including laboratory tests, imaging, and surgical outcomes.

Key Insights and Ideas

  • Severity, Not Just Presence: The study moves beyond the binary "PH or no PH" approach. It demonstrates that PH Grade 2 is a significantly stronger predictor of failure than Grade 1, suggesting a dose-response relationship between portal pressure and surgical risk.
  • The "Roadmap" Synergy: The most critical insight is how PH grade interacts with the extent of resection. In patients undergoing "minor" resections (less than three segments), PH Grade 2 increased the risk of failure, but many patients still fared well. However, in "extensive" resections, the risk skyrocketed.
  • Noninvasive Utility: The study proves that simple, "low-tech" markers (spleen size, platelets, and varices) provide enough prognostic information to guide major surgical decisions, potentially bypassing the need for invasive HVPG in many cases.

Key Results

  • PH Grade 2 as a Major Predictor: In the multivariate analysis, PH Grade 2 was associated with a more than two-fold increase in PHLF risk (OR = 2.222, p = 0.011).
  • The 100% Risk Threshold: In a subgroup analysis of extensive liver resections, 100% of patients with PH Grade 2 developed PHLF, compared to 60% for Grade 1 and 35.7% for Grade 0.
  • Other Significant Risk Factors: Beyond PH grade, the study identified several other independent predictors of PHLF:
  • Major Hepatectomy: OR 2.919
    • Hepatitis C Infection: OR 3.711
    • Open Surgery (vs. Laparoscopic): OR 2.336
    • Hyperbilirubinemia ($\geq 17.2 \mu mol/L$): OR 2.113
    • High Alpha-fetoprotein (> 400 ng/ml): OR 1.799

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: As a retrospective study, there is inherent potential for selection bias, though the authors attempted to mitigate this using PSM.
  • Etiology Bias: The cohort had a very high proportion of Hepatitis B (HBV) patients, which is typical in China but may not perfectly represent HCC populations in the West, where Alcohol or NASH-related cirrhosis is more common.
  • Lack of HVPG Correlation: While the noninvasive markers are practical, the study did not directly compare these grades to actual HVPG measurements in the same patients to "calibrate" the pressure levels.
  • Future Directions: The authors suggest that a large-scale, prospective multicenter study with external verification cohorts is needed to solidify these findings and integrate the "roadmap" into international clinical guidelines.

Summary updated

Abstract

PH is significantly related to the occurrence of PHLF in patients who underwent hepatectomy. Noninvasively assessing PH grade can predict PHLF risk.
BibTeX
@inproceedings{wang2022noninvasively,
  author = {Jitao Wang and Zhanguo Zhang and Dong Shang and Jinlong Li and Chengyu Liu and Peng Yu and Mingguang Wang and Dengxiang Liu and Hongrui Miao and Shuang Li and Biao Zhang and Anliang Huang and Yewei Zhang and Shubo Chen and Xiaolong Qi},
  title = {{Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.934870},
}
Figure